ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
I00-I99: Diseases of the circulatory system |
Stroke |
I61-I63, I80-I82 |
MMP9 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
PTPN1; HSD11B1 |
C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR |
G00-G99: Diseases of the nervous system G00-G99 |
Alzheimer disease |
G30 |
MAPT |
K00-K95: Diseases of the digestive system |
Ulcerative colitis |
K51 |
MMP9 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Pompe's disease |
E74.02 |
GAA |
E00-E89: Endocrine, nutritional and metabolic diseases |
Hypercholesterolemia |
E78 |
HSD11B1 |
C00-D49: Neoplasms |
Solid tumours |
C00-D48 |
HIF1A; CA9; MMP9; MMP2 |
C00-D49: Neoplasms |
Colorectal cancer |
C18-C21 |
MMP9 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoarthritis |
M15-M19, M47 |
MMP2 |
A00-B99: Certain infectious and parasitic diseases |
Infections |
A00-B99 |
PTPN1 |
C00-D49: Neoplasms |
Ovarian cancer |
C56 |
MMP2 |
K00-K95: Diseases of the digestive system |
Duodenal ulcers |
K25-K27 |
CA2; CA1 |
I00-I99: Diseases of the circulatory system |
High blood pressure |
I10-I16 |
CA2 |
NA: NA |
Edema |
NA |
CA2 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Contact dermatitis |
L23, L24, L25 |
PLA2G1B |
C00-D49: Neoplasms |
Non-small-cell lung cancer |
NA |
MMP2 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Non-insulin dependent diabetes |
E11.9 |
HSD11B1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Arthritis |
M00-M25 |
MMP1; PLA2G1B |
I00-I99: Diseases of the circulatory system |
Arteriosclerosis |
I70 |
PLA2G1B |
I00-I99: Diseases of the circulatory system |
Atherosclerosis |
I70 |
HSD11B1; MMP12 |
G00-G99: Diseases of the nervous system G00-G99 |
Neurodegenerative disease |
G30-G32 |
MAPT |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR |
NA: NA |
Colour dead tissues |
NA |
PTPN1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Acne vulgaris |
L70.0 |
MMP2 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Nerve injury |
T14.4 |
PLA2G1B |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Allergy |
T78.4 |
PLA2G1B |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Cognitive disorders |
F01-F07, F04, F05, R41.3 |
MAPT |
C00-D49: Neoplasms |
Clear cell renal cell carcinoma |
C64 |
CA9 |
C00-D49: Neoplasms |
Pancreatic cancer |
C25 |
MMP2 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
PTPN1; HSD11B1; HSD11B1 |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
MMP12; PLA2G1B |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses |
L20-L30 |
PLA2G1B |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Insomnia |
F51.0, G47.0 |
CA2 |
J00-J99: Diseases of the respiratory system |
Influenza virus |
J11.1 |
HSD11B1 |
H00-H59: Diseases of the eye and adnexa |
Open-angle glaucoma |
H40-H42 |
CA2; CA4 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic nephropathy |
E11.21 |
MMP1 |
H00-H59: Diseases of the eye and adnexa |
Chronic glaucoma |
H40-H42 |
CA1 |
C00-D49: Neoplasms |
Renal cancer |
C64 |
CA9 |
C00-D49: Neoplasms |
Renal cell carcinoma |
NA |
MMP2 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp |
L20-L30 |
PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
PTPN1; PTPN1; GPBAR1; HSD11B1; NFKB1 |
C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR |
G00-G99: Diseases of the nervous system G00-G99 |
Central nervous system disease |
G00-G99 |
MAPT |
L00-L99: Diseases of the skin and subcutaneous tissue |
Pruritus |
L29 |
PLA2G1B |
A00-B99: Certain infectious and parasitic diseases |
Visceral leishmaniasis |
B55.0 |
PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Lipid metabolism disorder |
E75-E78 |
HSD11B1 |
A00-B99: Certain infectious and parasitic diseases |
Leishmaniasis |
B55.0 |
PLA2G1B |
I00-I99: Diseases of the circulatory system |
Pulmonary arterial hypertension |
I27.0, I27.2 |
HIF1A |
C00-D49: Neoplasms |
Lymphoma |
C81-C86 |
HIF1A; CA9 |
C00-D49: Neoplasms |
Lung cancer |
C33-C34 |
MMP2 |
H00-H59: Diseases of the eye and adnexa |
Ocular hypertension |
H40.0 |
HSD11B1; CA4; CA4 |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
HIF1A; CA1; CA9; MMP9; NFKB1; MMP2; CDC25B |
I00-I99: Diseases of the circulatory system |
Aortic aneurysm |
I71 |
MMP12 |
I00-I99: Diseases of the circulatory system |
Edema associated with congestive heart failure |
I50, R60.9 |
CA2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
MMP1; PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic syndrome x |
E88.81 |
HSD11B1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
GPBAR1; HSD11B1 |
H00-H59: Diseases of the eye and adnexa |
Glaucoma |
H40-H42 |
CA1; CA1 |
C00-D49: Neoplasms |
Breast cancer |
C50 |
CA9 |
J00-J99: Diseases of the respiratory system |
Allergic rhinitis |
J00, J30, J31.0, T78.4 |
PLA2G1B |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
MMP12; PLA2G1B |
J00-J99: Diseases of the respiratory system |
Chronic obstructive pulmonary disease |
J40-J44, J47 |
MMP12; MMP12 |